Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Jones

Showing results (271-280 of 281) with videos related to

Pageof 29
Sort By:
Bone Marrow Transplantation|December 16, 1998
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignanciesP V O'Donnell, R J Jones, G B Vogelsang, et al.
Leukemia|August 27, 2010
High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemiasS Morisot, A S Wayne, O Bohana-Kashtan, et al.
Bone Marrow Transplantation|November 4, 2008
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimenJ Bolaños-Meade, L Luznik, M Muth, et al.
Experimental Hematology|November 8, 2001
The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemiaC B Miller, P A Rowlings, M J Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2001
Long-term results of blood and marrow transplantation for Hodgkin's lymphomaG Akpek, R F Ambinder, S Piantadosi, et al.
Neuroimage|November 15, 2021
Using diffusion MRI data acquired with ultra-high gradient strength to improve tractography in routine-quality dataC Maffei, C Lee, M Planich, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Chronic Myelogenous LeukemiaE Berman, R A Clift, E A Copelan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2025
Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems dataC Jones, P Dutey-Magni, L R Murphy, et al.
Investigational New Drugs|April 30, 2015
AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studiesA Omlin, R J Jones, R van der Noll, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2019
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trialN W Clarke, A Ali, F C Ingleby, et al.
Pageof 29

Showing results (271-280 of 281) with videos related to

Sort By:
Pageof 29
Bone Marrow Transplantation|December 16, 1998
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignanciesP V O'Donnell, R J Jones, G B Vogelsang, et al.
Leukemia|August 27, 2010
High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemiasS Morisot, A S Wayne, O Bohana-Kashtan, et al.
Bone Marrow Transplantation|November 4, 2008
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimenJ Bolaños-Meade, L Luznik, M Muth, et al.
Experimental Hematology|November 8, 2001
The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemiaC B Miller, P A Rowlings, M J Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2001
Long-term results of blood and marrow transplantation for Hodgkin's lymphomaG Akpek, R F Ambinder, S Piantadosi, et al.
Neuroimage|November 15, 2021
Using diffusion MRI data acquired with ultra-high gradient strength to improve tractography in routine-quality dataC Maffei, C Lee, M Planich, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Chronic Myelogenous LeukemiaE Berman, R A Clift, E A Copelan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2025
Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems dataC Jones, P Dutey-Magni, L R Murphy, et al.
Investigational New Drugs|April 30, 2015
AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studiesA Omlin, R J Jones, R van der Noll, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2019
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trialN W Clarke, A Ali, F C Ingleby, et al.
Pageof 29